{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:24:30Z","timestamp":1777530270867,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.otc.2004.02.007","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:11Z","timestamp":1113835991000},"page":"751-761","source":"Crossref","is-referenced-by-count":10,"title":["Significance of primary hyperparathyroidism in the management of osteoporosis"],"prefix":"10.1016","volume":"37","author":[{"given":"Tipu Faiz M","family":"Saleem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin","family":"Horwith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Brendan C","family":"Stack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.otc.2004.02.007_BIB1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-126-6-199703150-00003","article-title":"The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965\u20131992","volume":"126","author":"Wermers","year":"1997","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.otc.2004.02.007_BIB2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8529(05)70146-8","article-title":"Primary hyperparathyroidism. When to observe and when to operate","volume":"29","author":"Bilezikian","year":"2000","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"5","key":"10.1016\/j.otc.2004.02.007_BIB3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1359\/jbmr.1997.12.5.856","article-title":"Primary hyperparathyroidism: still evolving?","volume":"12","author":"Silverberg","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB4","first-page":"N98","article-title":"Bone densitometry in asymptomatic primary hyperparathyroidism","volume":"17","author":"Miller","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB5","first-page":"N103","article-title":"Fracture risk in primary hyperparathyroidism","volume":"17","author":"Khosla","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.otc.2004.02.007_BIB6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0272-2712(18)30053-2","article-title":"Parathyroid hormone. Does it have a role in the pathogenesis of osteoporosis?","volume":"20","author":"Bilezikian","year":"2000","journal-title":"Clin Lab Med"},{"issue":"6","key":"10.1016\/j.otc.2004.02.007_BIB7","first-page":"690","article-title":"Anabolic actions of parathyroid hormone on bone","volume":"14","author":"Dempster","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1016\/j.otc.2004.02.007_BIB8","series-title":"Osteoporosis","first-page":"266","article-title":"Skeletal growth factors","author":"Canalis","year":"1996"},{"key":"10.1016\/j.otc.2004.02.007_BIB9","series-title":"Anabolic treatment for osteoporosis","first-page":"185","article-title":"The insulin like growth factors: potential anabolic agents for the skeleton","author":"Johansson","year":"1998"},{"issue":"3","key":"10.1016\/j.otc.2004.02.007_BIB10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/er.20.3.345","article-title":"Modulation of osteoclast differentiation and function by new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.otc.2004.02.007_BIB11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1530\/eje.0.1420661","article-title":"Involvement of osteoprotegerin\/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells","volume":"142","author":"Kanzawa","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.otc.2004.02.007_BIB12","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/en.139.11.4743","article-title":"Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells","volume":"139","author":"Horwood","year":"1998","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.otc.2004.02.007_BIB13","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.otc.2004.02.007_BIB14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007740050055","article-title":"The role of integrins in osteoclast function","volume":"17","author":"Duong","year":"1999","journal-title":"J Bone Miner Metab"},{"issue":"10","key":"10.1016\/j.otc.2004.02.007_BIB15","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/jbmr.5650081003","article-title":"Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA","volume":"8","author":"Greenfield","year":"1993","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.otc.2004.02.007_BIB16","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1210\/en.140.10.4683","article-title":"A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo","volume":"140","author":"Grey","year":"1999","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.otc.2004.02.007_BIB17","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1172\/JCI117130","article-title":"Interleukin-11: a new cytokine critical for osteoclast development","volume":"93","author":"Girasole","year":"1994","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB18","first-page":"N95","article-title":"Primary hyperparathyroidism: lessons from bone histomorphometry","volume":"17","author":"Eriksen","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB19","first-page":"S97","article-title":"Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention","volume":"6","author":"Parfitt","year":"1991","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.otc.2004.02.007_BIB20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/8756-3282(93)90207-Q","article-title":"Primary hyperparathyroidism: iliac crest cortical thickness, structure, and remodeling evaluated by histomorphometric methods","volume":"14","author":"Christiansen","year":"1993","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.otc.2004.02.007_BIB21","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1210\/jc.84.5.1562","article-title":"On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism","volume":"84","author":"Dempster","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.otc.2004.02.007_BIB22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure","volume":"70","author":"Parisien","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.otc.2004.02.007_BIB23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00192633","article-title":"Trabecular bone structure in patients with primary hyperparathyroidism","volume":"426","author":"Vogel","year":"1995","journal-title":"Virchows Arch"},{"issue":"11","key":"10.1016\/j.otc.2004.02.007_BIB24","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1210\/jc.81.11.4007","article-title":"Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism","volume":"81","author":"Silverberg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 5","key":"10.1016\/j.otc.2004.02.007_BIB25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00198-003-1482-4","article-title":"Bone strength in primary hyperparathyroidism","volume":"14","author":"Bilezikian","year":"2003","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.otc.2004.02.007_BIB26","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","article-title":"Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course","volume":"67","author":"Rao","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 5","key":"10.1016\/j.otc.2004.02.007_BIB27","first-page":"13","article-title":"Bone strength in primary hyperparathyroidism","volume":"14","author":"Bilezikian","year":"2003","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.otc.2004.02.007_BIB28","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.1992.00400230081014","article-title":"Risk of age-related fractures in patients with primary hyperparathyroidism","volume":"152","author":"Melton","year":"1992","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.otc.2004.02.007_BIB29","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"Incipient primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.otc.2004.02.007_BIB30","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/en.140.9.4367","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB31","first-page":"N108","article-title":"Role of the interleukin-6\/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women","volume":"17","author":"Insogna","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.otc.2004.02.007_BIB32","first-page":"785","article-title":"The effect of ethinyloestradiol on calcium and phosphorus metabolism of post-menopausal women with primary hyperparathyroidism","volume":"45","author":"Gallagher","year":"1973","journal-title":"Clin Sci Mol Med"},{"issue":"17","key":"10.1016\/j.otc.2004.02.007_BIB33","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB34","first-page":"N103","article-title":"Fracture risk in primary hyperparathyroidism","volume":"17","author":"Khosla","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.otc.2004.02.007_BIB35","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.otc.2004.02.007_BIB36","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0002-9343(74)90812-2","article-title":"Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism","volume":"56","author":"Lumb","year":"1974","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.otc.2004.02.007_BIB37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","article-title":"The effects of vitamin D insufficiency in patients with primary hyperparathyroidism","volume":"107","author":"A Silverberg","year":"1999","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB38","first-page":"N98","article-title":"Bone densitometry in asymptomatic primary hyperparathyroidism","volume":"17","author":"Miller","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.otc.2004.02.007_BIB39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S8756-3282(99)00208-2","article-title":"Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study","volume":"25","author":"Christiansen","year":"1999","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.otc.2004.02.007_BIB40","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"87","author":"Bilezikian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.otc.2004.02.007_BIB41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1385\/JCD:4:1:63","article-title":"Diagnostic discrepancies between two closely related forearm bone density measurement sites","volume":"4","author":"Boyanov","year":"2001","journal-title":"J Clin Densitom"},{"issue":"3","key":"10.1016\/j.otc.2004.02.007_BIB42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.80.3.729","article-title":"Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism","volume":"80","author":"Silverberg","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.otc.2004.02.007_BIB43","first-page":"128","article-title":"Skeletal remineralization after surgery for primary and secondary hyperparathyroidism","volume":"107","author":"Abugassa","year":"1990","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.otc.2004.02.007_BIB44","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1210\/jc.83.3.732","article-title":"Marked improvement in bone mass after parathyroidectomy in osteitis fibrosa cystica","volume":"83","author":"Bilezikian","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.otc.2004.02.007_BIB45","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1359\/jbmr.2002.17.10.1741","article-title":"Parathyroid hormone and periosteal bone expansion","volume":"17","author":"Parfitt","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.otc.2004.02.007_BIB46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S8756-3282(98)00042-8","article-title":"Bone measurements in asymptomatic primary hyperparathyroidism","volume":"22","author":"Adami","year":"1998","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.otc.2004.02.007_BIB47","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1210\/jc.86.10.4576","article-title":"Clinical review 137: sexual dimorphism in skeletal size, density, and strength","volume":"86","author":"Seeman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"7261","key":"10.1016\/j.otc.2004.02.007_BIB48","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","article-title":"Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism","volume":"321","author":"Vestergaard","year":"2000","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.otc.2004.02.007_BIB49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.otc.2004.02.007_BIB50","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jbmr.5650070808","article-title":"Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis","volume":"7","author":"Parisien","year":"1992","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.otc.2004.02.007_BIB51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02058659","article-title":"The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae","volume":"3","author":"Rockoff","year":"1969","journal-title":"Calcif Tissue Res"},{"issue":"3","key":"10.1016\/j.otc.2004.02.007_BIB52","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1148\/radiology.179.3.2027972","article-title":"Effect of bone distribution on vertebral strength: assessment with patient-specific nonlinear finite element analysis","volume":"179","author":"Faulkner","year":"1991","journal-title":"Radiology"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB53","first-page":"N146","article-title":"The role of estrogens and related compounds in the management of primary hyperparathyroidism","volume":"17","author":"Marcus","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.otc.2004.02.007_BIB54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial","volume":"125","author":"Grey","year":"1996","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.otc.2004.02.007_BIB55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.otc.2004.02.007_BIB56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1359\/jbmr.2001.16.1.189","article-title":"Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism","volume":"16","author":"Zanchetta","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.otc.2004.02.007_BIB57","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jbmr.5650110615","article-title":"A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women","volume":"11","author":"Draper","year":"1996","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.otc.2004.02.007_BIB58","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.287.7.847","article-title":"MORE Investigators (Multiple Outcomes of Raloxifene Evaluation). Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial","volume":"287","author":"Barrett-Connor","year":"2002","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.otc.2004.02.007_BIB59","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB60","first-page":"N150","article-title":"Bisphosphonates and primary hyperparathyroidism","volume":"17","author":"Rodan","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.otc.2004.02.007_BIB61","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0889-8529(05)70149-3","article-title":"Medical approaches to primary hyperparathyroidism","volume":"29","author":"Strewler","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"10.1016\/j.otc.2004.02.007_BIB62","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1210\/jc.2002-021597","article-title":"The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism","volume":"88","author":"Shoback","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB63","first-page":"N141","article-title":"Calcimimetics in the treatment of primary hyperparathyroidism","volume":"17","author":"Antoniucci","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB64","first-page":"N154","article-title":"The basis for the post-parathyroidectomy increase in bone mass","volume":"17","author":"Heaney","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.007_BIB65","first-page":"S1","article-title":"Proceedings of the NIH Consensus Development Conference on diagnosis and management of asymptomatic primary hyperparathyroidism. Bethesda, Maryland, October 29\u201331, 1990","volume":"6","author":"National Institute of Health","year":"1991","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.otc.2004.02.007_BIB66","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-114-7-593","article-title":"NIH Conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference statement","volume":"114","author":"National Institute of Health","year":"1991","journal-title":"Ann Intern Med"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666504000453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666504000453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T23:27:50Z","timestamp":1550100470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666504000453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0030666504000453"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2004.02.007","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}